01 — At a Glance
The Flexible Packaging Gamble That Keeps Flexing Wallets
- 52-Week High / Low₹686 / ₹434
- Q3 FY26 Revenue₹3,612 Cr
- Q3 FY26 PAT₹361 Cr
- Q3 EPS (₹)5.01
- Annualised EPS (Q3×4)₹20.04
- Book Value₹1,070
- Price to Book0.41x
- Dividend Yield0.70%
- Debt / Equity1.21x
- Net Debt₹7,281 Cr
The Packager’s Paradox: Uflex closed Q3 FY26 with revenue of ₹3,612 crore (down 3.8% YoY), PAT of ₹361 crore (down 66.6%), and announced it’s building four new factories simultaneously on a debt pile of ₹9,326 crore. The P/E of 13.2x looks cheap until you realize the company’s ROCE is 7.75% — the kind of return your FD gives you for literally zero risk and zero existential dread.
02 — Introduction
Welcome to the Flexible Packaging Theatre Where Budgets Are Infinite But Returns Ain’t
Uflex Ltd. The name suggests flexibility. The financials suggest Arjun Reddy-level emotional volatility. A global flexible packaging manufacturer with 16 factories across 5 continents, serving Nestlé, Mondelez, Amul, Coca-Cola, and basically everyone who has ever needed plastic that doesn’t make crinkly sounds at a movie theatre.
Founded decades ago, this Mumbai-listed behemoth manufactures ~647,000 MT of films annually. It does BOPET, BOPP, CPP, metallized films, holographic packaging — basically the entire periodic table of “stuff that keeps your stuff fresh.” Market cap ₹3,142 crore. Book value of ₹19.71 per share (EPS). But here’s the kicker: the company is currently deploying ₹2,000+ crore on new capex projects in Egypt, Mexico, and India while simultaneously asking how it’ll ever generate adequate returns on past capex.
Q3 FY26 delivered a gut punch. Revenue down 3.8% YoY. PAT down 66.6%. But management held a concall in Feb 2026 and calmly announced that everything is “showing signs of normalization” and that film prices (which collapsed to ₹90/kg) have recovered to ₹110/kg. Translation: we’re expecting margin improvement because things can’t get worse. Groundbreaking logic.
This is a company in love with capex the way a startup founder is in love with burn rate. Every quarter, another announcement: Egypt facility coming, Mexico facility coming, Dharwad facility coming. Debt peak? Maybe. Leverage improvement? “We’re confident.” Cash conversion? Let’s revisit this in 2027.
Concall Gem (Feb 2026): “We see this leverage ratio more or less being at the peak… not necessarily reflecting in the reduced debt number, but… improvement in the leverage ratio.” Basically: debt isn’t shrinking, but if EBITDA grows, our leverage ratio looks better. The accounting equivalent of putting on a new suit to hide a weight gain.
03 — Business Model: What’s Inside the Bubble?
Plastic Films. Plastic Bags. Plastic Everything. All Plastic, All The Time.
Uflex manufactures flexible packaging films — the translucent, crinkly stuff that makes a noise every time your kids reach into a snack packet. Geographically: India (46% revenue), Americas (19%), Europe (17%), Middle East & Africa (16%), others (2%). Segment-wise: Packaging Films (62% revenue) and Value-Added Products (38% revenue, which includes specialty packaging, liquid packaging, holography, chemicals, and machinery).
The unit economics are straightforward: buy resin pellets → extrude into films → ship globally → pray raw material prices don’t crater overnight. For 16 years, Uflex did exactly this. Returns were adequate. Debt was manageable. Then came the grand capex ambition.
In Q1 FY25, management decided the world needed more film capacity. Specifically: 216,000 MTPA virgin PET chips line in Egypt (started commissioning Q3 FY26), 80,000 MTPA woven polypropylene bags in Mexico (also Q3-Q1 commissioning window), and a 54,000 MTPA BOPP line in Dharwad (approved Nov 2025, completion by FY2027-28). Total capex across three projects: >₹2,000 crore. Funding source: debt. Revenue impact: TBD.
This is what happens when a manufacturer watches margins compress in developed markets and decides the solution is to build factories at 3x capex intensity in frontier geographies.
India Revenue46%Largest market
Films Capacity618k MTAnnual rated
Global Plants165 continents
Top Customer8%Diversified base
The Leverage Love Story: As of Sept 2025, Uflex had ₹9,326 crore in debt against equity of ₹7,655 crore (Sep 2025 balance sheet). Debt/Equity = 1.21x. Interest coverage = 1.39x. That’s not a ratio. That’s a cry for help. Management reiterates leverage is “peaking” but given capex visibility of ₹350+ crore in Egypt alone through Q1 FY27, “peaking” might be a generous word choice.
💬 Which is scarier: a company that stops investing in growth, or a company that keeps investing but can’t generate returns on it? Uflex is playing both.
04 — Financials Overview
Q3 FY26: The Quarterly Squeeze
Result type: Quarterly Results | Q3 FY26 EPS: ₹5.01 | Annualised EPS (Q3×4): ₹20.04 | FY26 Full-Year EPS Guidance: Linked to EBITDA Rs. 1,800–1,850 Cr
| Metric (₹ Mn) |
Q3 FY26
Dec 2025 |
Q3 FY25
Dec 2024 |
Q2 FY26
Sep 2025 |
YoY % |
QoQ % |
| Revenue | 36,329 | 37,775 | 38,321 | -3.8% | -5.2% |
| EBITDA (Reported) | 4,596 | 4,197 | 3,869 | +9.5% | +18.8% |
| EBITDA Margin % | 12.7% | 11.1% | 10.1% | +160 bps | +260 bps |
| PAT | 361 | 1,079 | 269 | -66.6% | +34.2% |
| EPS (₹) | 5.01 | 14.95 | 3.73 | -66.5% | +34.3% |
The Margin Bounce & Earnings Collapse Paradox: EBITDA margin expanded 160 bps YoY to 12.7%, driven by (a) film price recovery from ₹90/kg to ₹110/kg, and (b) lower “exceptional impact” vs Q3 FY25. But PAT collapsed 66.6% because Q3 FY25 had a one-time labour code benefit that inflated that quarter’s profitability. When you strip normalization: operating performance is fine, capital structure is scary, and leverage is at “peak levels” (management’s own words). FY26 guidance remains EBITDA Rs. 1,800–1,850 crore (~12% margin). Annualized EPS from Q3 (₹20.04) is misleading; wait for full-year actuals.
05 — Valuation Discussion: Fair Value Range Only
What’s This Global Plastic Factory Worth?
